The front-end of the clinical trial data collection process is known for its cumbersome characteristics: large paper volume, completed in quickly-penned, difficult- to-decipher handwriting, fraught with transcription errors—time-consuming all around. Industry observers say a paper-based process can add 12 to 15 weeks to the trial time with each day's delay often worth $1 million or more in lost revenue.
Privately-held PHT Corp. addressed these problems with a product that recognizes what the FDA has called for in its...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?